{"id":6075,"date":"2021-10-01T08:51:36","date_gmt":"2021-10-01T08:51:36","guid":{"rendered":"https:\/\/r-biopharm.com\/?p=6075"},"modified":"2022-03-03T09:35:43","modified_gmt":"2022-03-03T09:35:43","slug":"ute-salzbrenner-ist-neue-cfo-bei-r-biopharm","status":"publish","type":"post","link":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/","title":{"rendered":"Ute Salzbrenner ist neue CFO bei R-Biopharm"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_single_image image=&#8220;6076&#8243; img_size=&#8220;large&#8220; alignment=&#8220;center&#8220;][vc_column_text css=&#8220;.vc_custom_1634546870442{margin-bottom: 0px !important;}&#8220;]Der Aufsichtsrat der R-Biopharm AG hat Ute Salzbrenner (55) zum Chief Financial Officer benannt. Zum 1. Oktober 2021 \u00fcbernimmt die Diplom-Volkswirtin als f\u00fcnftes Vorstandsmitglied den Bereich Finanzen.<\/p>\n<p>Ute Salzbrenner wird in ihrer neuen Rolle die Entwicklung und Umsetzung der langfristigen Finanz- und Marktexpansionsstrategie von R-Biopharm\u00a0 unterst\u00fctzen. \u201eDas versetzt uns in die Lage, den steigenden Herausforderungen, die durch das starke Wachstum entstanden sind, noch besser gerecht zu werden\u201c, sagt CEO Christian Dreher. \u201eIch freue mich, dass Ute Salzbrenner mit ihrer langj\u00e4hrigen Expertise den Wachstumskurs von R-Biopharm strategisch mitgestalten wird.\u201c<\/p>\n<p>Vor ihrem Wechsel zu R-Biopharm war Ute Salzbrenner f\u00fcr die Felss-Gruppe als CFO t\u00e4tig sowie als Finanzvorstand f\u00fcr unterschiedliche Unternehmen, haupts\u00e4chlich aus der Automobilbranche.[\/vc_column_text][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8220;6076&#8243; img_size=&#8220;large&#8220; alignment=&#8220;center&#8220;][vc_column_text css=&#8220;.vc_custom_1634546870442{margin-bottom: 0px !important;}&#8220;]Der Aufsichtsrat der R-Biopharm AG hat Ute Salzbrenner (55) zum Chief Financial Officer benannt. Zum 1. Oktober 2021 \u00fcbernimmt die Diplom-Volkswirtin als f\u00fcnftes Vorstandsmitglied den Bereich Finanzen. Ute Salzbrenner wird in ihrer neuen Rolle die Entwicklung und Umsetzung der langfristigen Finanz- und Marktexpansionsstrategie von R-Biopharm\u00a0 unterst\u00fctzen. \u201eDas versetzt uns [&hellip;]<\/p>\n","protected":false},"author":1114,"featured_media":6076,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[351],"tags":[],"class_list":["post-6075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsarchiv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_single_image image=&#8220;6076&#8243; img_size=&#8220;large&#8220; alignment=&#8220;center&#8220;][vc_column_text css=&#8220;.vc_custom_1634546870442{margin-bottom: 0px !important;}&#8220;]Der Aufsichtsrat der R-Biopharm AG hat Ute Salzbrenner (55) zum Chief Financial Officer benannt. Zum 1. Oktober 2021 \u00fcbernimmt die Diplom-Volkswirtin als f\u00fcnftes Vorstandsmitglied den Bereich Finanzen. Ute Salzbrenner wird in ihrer neuen Rolle die Entwicklung und Umsetzung der langfristigen Finanz- und Marktexpansionsstrategie von R-Biopharm\u00a0 unterst\u00fctzen. \u201eDas versetzt uns [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/\" \/>\n<meta property=\"og:site_name\" content=\"R-Biopharm AG\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-01T08:51:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-03T09:35:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1400\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"niclas\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"niclas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/\"},\"author\":{\"name\":\"niclas\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\"},\"headline\":\"Ute Salzbrenner ist neue CFO bei R-Biopharm\",\"datePublished\":\"2021-10-01T08:51:36+00:00\",\"dateModified\":\"2022-03-03T09:35:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/\"},\"wordCount\":152,\"image\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/ute_salzbrenner.jpg\",\"articleSection\":[\"Newsarchiv\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/\",\"name\":\"Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/ute_salzbrenner.jpg\",\"datePublished\":\"2021-10-01T08:51:36+00:00\",\"dateModified\":\"2022-03-03T09:35:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/ute_salzbrenner.jpg\",\"contentUrl\":\"https:\\\/\\\/r-biopharm.com\\\/wp-content\\\/uploads\\\/ute_salzbrenner.jpg\",\"width\":1400,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ute Salzbrenner ist neue CFO bei R-Biopharm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#website\",\"url\":\"https:\\\/\\\/r-biopharm.com\\\/\",\"name\":\"R-Biopharm AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/r-biopharm.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/r-biopharm.com\\\/#\\\/schema\\\/person\\\/1f2853ffae1847d6375c365a249e8cb4\",\"name\":\"niclas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g\",\"caption\":\"niclas\"},\"url\":\"https:\\\/\\\/r-biopharm.com\\\/de\\\/author\\\/niclas\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/","og_locale":"de_DE","og_type":"article","og_title":"Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG","og_description":"[vc_row][vc_column][vc_single_image image=&#8220;6076&#8243; img_size=&#8220;large&#8220; alignment=&#8220;center&#8220;][vc_column_text css=&#8220;.vc_custom_1634546870442{margin-bottom: 0px !important;}&#8220;]Der Aufsichtsrat der R-Biopharm AG hat Ute Salzbrenner (55) zum Chief Financial Officer benannt. Zum 1. Oktober 2021 \u00fcbernimmt die Diplom-Volkswirtin als f\u00fcnftes Vorstandsmitglied den Bereich Finanzen. Ute Salzbrenner wird in ihrer neuen Rolle die Entwicklung und Umsetzung der langfristigen Finanz- und Marktexpansionsstrategie von R-Biopharm\u00a0 unterst\u00fctzen. \u201eDas versetzt uns [&hellip;]","og_url":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/","og_site_name":"R-Biopharm AG","article_published_time":"2021-10-01T08:51:36+00:00","article_modified_time":"2022-03-03T09:35:43+00:00","og_image":[{"width":1400,"height":1000,"url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg","type":"image\/jpeg"}],"author":"niclas","twitter_misc":{"Verfasst von":"niclas","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#article","isPartOf":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/"},"author":{"name":"niclas","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"headline":"Ute Salzbrenner ist neue CFO bei R-Biopharm","datePublished":"2021-10-01T08:51:36+00:00","dateModified":"2022-03-03T09:35:43+00:00","mainEntityOfPage":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/"},"wordCount":152,"image":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg","articleSection":["Newsarchiv"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/","url":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/","name":"Ute Salzbrenner ist neue CFO bei R-Biopharm - R-Biopharm AG","isPartOf":{"@id":"https:\/\/r-biopharm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#primaryimage"},"image":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#primaryimage"},"thumbnailUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg","datePublished":"2021-10-01T08:51:36+00:00","dateModified":"2022-03-03T09:35:43+00:00","author":{"@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4"},"breadcrumb":{"@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#primaryimage","url":"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg","contentUrl":"https:\/\/r-biopharm.com\/wp-content\/uploads\/ute_salzbrenner.jpg","width":1400,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/r-biopharm.com\/de\/ute-salzbrenner-ist-neue-cfo-bei-r-biopharm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/r-biopharm.com\/de\/"},{"@type":"ListItem","position":2,"name":"Ute Salzbrenner ist neue CFO bei R-Biopharm"}]},{"@type":"WebSite","@id":"https:\/\/r-biopharm.com\/#website","url":"https:\/\/r-biopharm.com\/","name":"R-Biopharm AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/r-biopharm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/r-biopharm.com\/#\/schema\/person\/1f2853ffae1847d6375c365a249e8cb4","name":"niclas","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1dfb0993bf8db0eca7425703a4efa851020c2ae35c8fa06cb76e6981abceeb33?s=96&d=mm&r=g","caption":"niclas"},"url":"https:\/\/r-biopharm.com\/de\/author\/niclas\/"}]}},"_links":{"self":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/6075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/users\/1114"}],"replies":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/comments?post=6075"}],"version-history":[{"count":3,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/6075\/revisions"}],"predecessor-version":[{"id":6084,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/posts\/6075\/revisions\/6084"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/media\/6076"}],"wp:attachment":[{"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/media?parent=6075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/categories?post=6075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/r-biopharm.com\/de\/wp-json\/wp\/v2\/tags?post=6075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}